SteroTherapeutics is pursuing a novel drug therapy for Non-alcoholic steatohepatitis.

Biotechnology

Pharmaceutical

SteroTherapeutics

SteroTherapeutics' headquarters in Spring House, PA, United States

Manohar Katakam

Lisa Sher

Arthur Schwartz

Carroll Allen

David Johnston

Roberto Salvatori

Arun J. Sanyal

Scott L Friedman

Andre Lacroix

W. Bryan Burnette

The Leadership Team at SteroTherapeutics plays a critical role in guiding the company's strategic direction and operational effectiveness. Comprising experts in scientific and regulatory affairs, as well as financial management, this team collaborates to drive the development of innovative therapies for Non-alcoholic steatohepatitis while ensuring compliance with industry regulations and safeguarding the company's financial health. Their collective expertise shapes the vision and execution of SteroTherapeutics' mission.

Leadership Team

The Regulatory and Scientific Affairs team at SteroTherapeutics is responsible for navigating the regulatory landscape to ensure the compliance and approval of the company’s novel drug therapy for Non-alcoholic steatohepatitis. They collaborate closely with clinical advisors to design and implement research protocols, analyze scientific data, and communicate findings to regulatory bodies, ultimately aiming to facilitate efficient drug development and market entry.

SteroTherapeutics

Org chart

Board & advisors

Teams

Leadership Team

Regulatory and Scientific Affairs

Offices

SteroTherapeutics

Org chart

Board & advisors

Teams

Leadership Team

Regulatory and Scientific Affairs

Offices

Related companies